Theon International Plc has agreed to purchase a 9.8% stake in Exosens SA for €268.7 million, making them the second largest shareholder in the company. Exosens specializes in electro-optical technologies and the transaction is expected to close in early 2026. UBS Europe SE and Citibank Europe PLC will provide a bridge facility for the deal, with UBS acting as financial advisor to Theon. Theon’s CEO expressed commitment to their commercial relationship with Exosens, a partnership that has secured contracts in Europe and the Middle East. For more information, contact Investor Relations or Media Relations at Theon.

Read more at GlobeNewswire: THEON plans to acquire 9.8% stake in Exosens